Xenon Pharmaceuticals Inc.
XENE
|
|
| |
|
| Trading Volume | 12,854 |
|
|
50.04 - 28.70 |
| Market Cap Full | $ 2.6B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 3.3% | -6.4% | -9.2% | -2.1% |
| Q2 | - | -11.3% | 7.6% | -0.5% |
| Q3 | - | -6.5% | -11.3% | 18.7% |
| Q4 | - | -12.6% | 39.3% | 9.2% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -1.8 | 4.4 | -8.7 | -7.4 | -4.6 | -1.8 | 15.3 | -6.5 | - | - | - | -8 |
| 2023 | |||||||||||
| -0.9 | 1 | -9.3 | 12.6 | -4.3 | -0.1 | -4.1 | 5.6 | -12.4 | -9.3 | 18 | 25.9 |
| 2022 | |||||||||||
| -13.2 | 16.9 | -3.6 | -7.1 | -7.3 | 15.5 | 9 | 17.7 | -7.5 | 1.3 | 0.9 | 6.9 |
| 2021 | |||||||||||
| -4.9 | 27.8 | -3.6 | 1.8 | 0.8 | 0.8 | -7.3 | 2.2 | -13.4 | 103.9 | -15.4 | 18.6 |
| 2020 | |||||||||||
| 10.8 | -4.4 | -19 | 14.3 | 5.7 | -8.5 | -12.8 | 11.2 | -10.3 | -9.9 | 21.1 | 29.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.6 | -0.4 | -0.4 | -0.2 |
| Q2 | -0.7 | -0.6 | -0.5 | 0 |
| Q3 | -0.7 | -0.6 | -0.4 | -0.3 |
| Q4 | 0 | -0.6 | -0.5 | -0.3 |
| A | -2.08 | -2.1 | -1.8 | -0.8 |